Saoussen Oueslati

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 18

Top Topics

Cystic Fibrosis

Biofilm Formation

Top Venues

Diagnostics (Basel, Switzerland)

Antibiotics (Basel, Switzerland)

Pathogens (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Camille Gonzalez, Saoussen Oueslati, Mariam Rima, Réva Nermont, Laurent Dortet, Katie L Hopkins, Bogdan I Iorga, Remy A Bonnin, Thierry Naas
Molecular, Genetic, and Biochemical Characterization of OXA-484 Carbapenemase, a Difficult-to-Detect R214G Variant of OXA-181. Microorganisms 12 (7) (2024)
Chahrazed Yousfi, Saoussen Oueslati, Dina Daaboul, Delphine Girlich, Alexis Proust, Chafia Bentchouala, Thierry Naas
Antibiotic Susceptibility Profiles of Bacterial Isolates Recovered from Abscesses in Cattle and Sheep at a Slaughterhouse in Algeria. Microorganisms 12 (3) (2024)
Chahrazed Yousfi, Saoussen Oueslati, Dina Daaboul, Delphine Girlich, Alexis Proust, Chafia Bentchouala, Thierry Naas
Antibiotic Susceptibility Profiles of Bacterial Isolates Recovered from Abscesses in Cattle and Sheep at a Slaughterhouse in Algeria. Microorganisms 12 (3) (2024)
Chahrazed Yousfi, Saoussen Oueslati, Dina Daaboul, Delphine Girlich, Alexis Proust, Chafia Bentchouala, Thierry Naas
Antibiotic Susceptibility Profiles of Bacterial Isolates Recovered from Abscesses in Cattle and Sheep at a Slaughterhouse in Algeria. Microorganisms 12 (3) (2024)
Camille Gonzalez, Saoussen Oueslati, Mariam Rima, Réva Nermont, Laurent Dortet, Katie L Hopkins, Bogdan I Iorga, Remy A Bonnin, Thierry Naas
Molecular, Genetic, and Biochemical Characterization of OXA-484 Carbapenemase, a Difficult-to-Detect R214G Variant of OXA-181. Microorganisms 12 (7) (2024)
Camille Gonzalez, Saoussen Oueslati, Mariam Rima, Réva Nermont, Laurent Dortet, Katie L Hopkins, Bogdan I Iorga, Remy A Bonnin, Thierry Naas
Molecular, Genetic, and Biochemical Characterization of OXA-484 Carbapenemase, a Difficult-to-Detect R214G Variant of OXA-181. Microorganisms 12 (7) (2024)
Mariam Rima, Niels Pfennigwerth, Martina Cremanns, Katarina Cirnski, Saoussen Oueslati, Sören G Gatermann, Nicola d'Amélio, Jennifer Herrmann, Daniel Krug, Thierry Naas
In Vitro Activity of Two Novel Antimicrobial Compounds on MDR-Resistant Clinical Isolates. Antibiotics (Basel, Switzerland) 12 (8) (2023)
Alessandra Natale, Saoussen Oueslati, Alice Rochard, Sien Ombelet, Daniel Lopez-Baez, Liselotte Hardy, Jane Cunningham, Céline Franquesa, Olivier Vandenberg, null null, Jean-Baptiste Ronat, Thierry Naas
Evaluation of InTray Cassettes Directly from Blood Cultures for the Diagnosis of Sepsis in Clinical Bacteriology Laboratories as an Alternative to Classic Culture Media. Diagnostics (Basel, Switzerland) 13 (3) (2023)
Alessandra Natale, Saoussen Oueslati, Alice Rochard, Sien Ombelet, Daniel Lopez-Baez, Liselotte Hardy, Jane Cunningham, Céline Franquesa, Olivier Vandenberg, null null, Jean-Baptiste Ronat, Thierry Naas
Evaluation of InTray Cassettes Directly from Blood Cultures for the Diagnosis of Sepsis in Clinical Bacteriology Laboratories as an Alternative to Classic Culture Media. Diagnostics (Basel, Switzerland) 13 (3) (2023)
Alexandru Andrei Muntean, Madalina-Maria Muntean, Saoussen Oueslati, Remy A Bonnin, Thierry Naas, Mircea Ioan Popa
Comment on Mitteregger et al. A Variant Carbapenem Inactivation Method (CIM) for Acinetobacter baumannii Group with Shortened Time-to-Result: rCIM-A. Pathogens 2022, 11 , 482. Pathogens (Basel, Switzerland) 11 (7) (2022)
Laura Dabos, Saoussen Oueslati, Sandrine Bernabeu, Remy A Bonnin, Laurent Dortet, Thierry Naas
To Be or Not to Be an OXA-48 Carbapenemase. Microorganisms 10 (2) (2022)
Camille Gonzalez, Christian Moguet, Arnaud Chalin, Saoussen Oueslati, Laurent Dortet, Stéphanie Simon, Hervé Volland, Thierry Naas
Comparison of Three Expanded-Spectrum Cephalosporin Hydrolysis Assays and the NG-Test CTX-M Multi Assay That Detects All CTX-M-Like Enzymes. Diagnostics (Basel, Switzerland) 12 (1) (2022)
Mariam Rima, Saoussen Oueslati, Laura Dabos, Dina Daaboul, Hassan Mallat, Elie Bou Raad, Marcel Achkar, Osman Mawlawi, Sandrine Bernabeu, Remy A Bonnin, Delphine Girlich, Marwan Osman, Mounzer Hamze, Thierry Naas
Prevalence and Molecular Mechanisms of Carbapenem Resistance among Gram-Negative Bacilli in Three Hospitals of Northern Lebanon. Antibiotics (Basel, Switzerland) 11 (10) (2022)
Camille Gonzalez, Saoussen Oueslati, Laura Biez, Laurent Dortet, Thierry Naas
Evaluation of the EasyScreen™ ESBL/CPO Detection Kit for the Detection of ß-Lactam Resistance Genes. Diagnostics (Basel, Switzerland) 12 (9) (2022)
Saoussen Oueslati, Melek Manai Bouokazi, Ikrame Ramdhani, Lélia Escaut, Tai Pham, Souad Ouzani, Nadia Anguel, Sophie Bulifon, Christelle Vauloup-Fellous, Audrey Coilly, Laurence Legros, Magali Guichardon, Nicolas Fortineau, Laurent Dortet, Anne-Marie Roque-Afonso, Thierry Naas
Clinical Added Value of SARS-CoV-2 Antigen Detection in Blood Samples. Diagnostics (Basel, Switzerland) 12 (10) (2022)
Jean-Baptiste Ronat, Saoussen Oueslati, Alessandra Natale, Thomas Kesteman, Wael Elamin, Céline Langendorf, Liselotte Hardy, Olivier Vandenberg, Thierry Naas
Validation of Three MicroScan ® Antimicrobial Susceptibility Testing Plates Designed for Low-Resource Settings. Diagnostics (Basel, Switzerland) 12 (9) (2022)
Saoussen Oueslati, Pierre Bogaerts, Laurent Dortet, Sandrine Bernabeu, Hend Ben Lakhal, Christopher M Longshaw, Youri Glupczynski, Thierry Naas
In vitro Activity of Cefiderocol and Comparators against Carbapenem-Resistant Gram-Negative Pathogens from France and Belgium. Antibiotics (Basel, Switzerland) 11 (10) (2022)
Saoussen Oueslati, Camille Gonzalez, Hervé Volland, Vincent Cattoir, Sandrine Bernabeu, Delphine Girlich, Duncan Dulac, Marc Plaisance, Laure Boutigny, Laurent Dortet, Stéphanie Simon, Thierry Naas
Rapid Detection of VanA/B-Producing Vancomycin-Resistant Enterococci Using Lateral Flow Immunoassay. Diagnostics (Basel, Switzerland) 11 (10) (2021)